< Back to search
Filter
1

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

for
Renal Cell Carcinoma (RCC),
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT05176483

Phase1, Recruiting

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Boston MA, New York NY, Durham NC, Sarasota FL,
Sponsor: Bristol-Myers Squibb

Sex: Male

Age: 18+

Code: NCT06067841

Phase1, Recruiting

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostate Cancer
Location: Boston MA, Newton MA, Lake Success NY, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: Male

Age: 18+

Code: NCT07244341

Phase1, Recruiting

Four-Timepoint Multi-tracer PET Imaging to Characterize Metastatic prOstate Cancer Heterogeneity

for
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Location: Quebec
Sponsor: Frederic Pouliot

Sex: Male

Age: 18+

Code: NCT07302763

Recruiting

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

for
Advanced or Metastatic Adrenocortical Carcinoma,
Location: Providence RI, New York NY, Sarasota FL
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07189403

Phase1, Recruiting

Interested in new metastatic castration-resistant prostate cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

for
Prostate Cancer (Adenocarcinoma),
Location: Boston MA, New York NY, Philadelphia PA, Madison WI,
Sponsor: Prostate Cancer Clinical Trials Consortium

Sex: Male

Age: 18+

Code: NCT06844383

Phase2, Recruiting

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-Resistant Prostate Cancer
Location: New Haven CT, Myrtle Beach SC, Charlottesville VA,
Sponsor: Kyntra Bio

Sex: Male

Age: 18+

Code: NCT06842498

Phase2, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase3, Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Charlotte NC, Canton OH, Jeffersonville IN, Houston TX,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase3, Recruiting

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

for
Metastatic Castration-resistant Prostate Cancer,
Location: New Hyde Park NY, New York NY, Myrtle Beach SC,
Sponsor: K36 Therapeutics, Inc.

Sex: Male

Age: 18+

Code: NCT07103018

Phase1, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Boston MA, Hartford CT, Quebec, Mineola NY, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase3, Recruiting

The COSMYC Trial (COmbined Suppression of MYC)

for
Metastatic Castration-resistant Prostate Cancer
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: Male

Age: 18+

Code: NCT06922318

Phase2, Recruiting

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

for
Metastatic Prostate Cancer,
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center

Sex: All

Age: 19+

Code: NCT06738303

Phase2, Recruiting

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Location: Los Angeles CA
Sponsor: Charles Drew University of Medicine and Science

Sex: Male

Age: 18+

Code: NCT06615752

Phase1, Phase2, Recruiting

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

for
PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy,
Location: El Paso TX, Murray UT, Los Angeles CA
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07226986

Phase1, Phase2, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: North Hills NY, Bala-Cynwyd PA, Virginia Beach VA,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase2, Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Myrtle Beach SC, Nashville TN, Omaha NE, Irving TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase1, Recruiting

Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

for
Metastatic Castration-resistant Prostate Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06100705

Phase2, Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

for
Advanced Metastatic Castration Resistant Prostate Cancer
Location: Fairfax VA, Houston TX, San Antonio TX, Spokane WA,
Sponsor: Shenzhen Ionova Life Sciences Co., Ltd.

Sex: Male

Age: 18+

Code: NCT06609005

Phase1, Phase2, Recruiting

Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

for
Metastatic Castration-Resistant Prostate Cancer,
Location: Houston TX
Sponsor: Ebrahim S Delpassand

Sex: Male

Age: 18+

Code: NCT06972628

Phase2, Recruiting